Guardian Pharmacy Services, Inc. GRDN
At closeNov 4, 2026, 4:01 PM EST
After hours · Nov 4, 4:01 PM ET
- YTD
- +39.88%
- 1 year
- +47.74%
- Market cap
- 2.67B
- Revenue (ttm)
- 1.46B
- Profit margin
- 4.50%
- EPS (ttm)
- 1.03
- Shares out
- 63.32M
- P/E ratio
- 40.86
- Forward P/E
- 29.33
- YTD return
- +39.88%
- 1-year return
- +47.74%
- Volume
- 658.23K
- Avg volume
- 501.62K
- Open
- 41.47
- Previous close
- 40.87
- Day's range
- 41.36 – 43.09
- 52-week range
- 26.34 – 48.33
- Beta
- 0.06
- Analysts
- Strong Buy
- Price target
- 49.86 (+18.5%)
- Earnings date
- Nov 5, 2026
5D -0.10 (-0.24%)
Key statistics
- Enterprise value
- 2.55B
- PEG ratio
- 0.00
- Price / sales
- 1.82
- Price / book
- 10.85
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 2.20%
- Free cash flow
- 64.55M
- Total cash
- 89.81M
- Total debt
- 39.27M
- Return on equity
- 30.42%
- Short % of float
- 4.71%
- 50-day average
- 41.16
- 200-day average
- 38.20
Analyst view
Consensus: strong buy
- Target (low)
- 47.00
- Target (mean)
- 49.86
- Target (high)
- 52.00
- Strong buy1
- Buy6
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 0.31429.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 0.3146 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 0.2617 | 0.29 | +0.03 | +10.81% |
| May 6, 2026 | Mar 31, 2026 | 0.24 | 0.29 | +0.05 | +20.83% |
| Mar 11, 2026 | Dec 31, 2025 | 0.27 | 0.37 | +0.10 | +37.04% |
| Nov 10, 2025 | Sep 30, 2025 | 0.24 | 0.25 | +0.01 | +4.17% |
| Aug 11, 2025 | Jun 30, 2025 | 0.22 | 0.23 | +0.01 | +4.55% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 23, 2026 | Keybanc | init | — | Overweight |
| Sep 21, 2026 | Truist Securities | main | Buy | Buy |
| Aug 7, 2026 | Oppenheimer | main | Outperform | Outperform |
| Jun 17, 2026 | Truist Securities | main | Buy | Buy |
| Jun 17, 2026 | B of A Securities | main | Buy | Buy |
| May 7, 2026 | Oppenheimer | main | Outperform | Outperform |
About Guardian Pharmacy Services, Inc.
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. The company's individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. Its Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs. Guardian Pharmacy Services, Inc. was founded in 2003 and is headquartered in Atlanta, Georgia.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- guardianpharmacy.com
News
Guardian Pharmacy Services, Inc. to Participate in Upcoming Stephens Investment Conference 
Guardian Pharmacy Services Acquires Van's Institutional Pharmacy, Expanding Footprint in Tennessee and Kentucky 
Guardian Pharmacy Services, Inc. to Report Third Quarter 2026 Financial Results and Host Conference Call 
Transcript: Guardian Pharmacy Service Q2 2026 Earnings Conference Call 
Bet on Winning DuPont Analysis & Pick 5 Top Stocks 
This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday 
Keybanc Initiates Coverage On Guardian Pharmacy Service with Overweight Rating, Announces Price Target of $52 
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $51 
Guardian Pharmacy Services, Inc. (NYSE:GRDN) Given Average Recommendation of “Moderate Buy” by Analysts 
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
Your note
Sign in to keep a note on GRDN — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ACKERMAN JOHN | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 24, 2026 | 0 |
| BINDLEY CAPITAL PARTNERS I, L.L.C | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 24, 2026 | 16,669,700 |
| BINDLEY WILLIAM E | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 24, 2026 | 0 |
| BURKE FRED | Chief Executive Officer | Conversion of Exercise of derivative security | Sep 24, 2026 | 3,438,060 |
| CARDINAL EQUITY FUND L P | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 24, 2026 | 1,287,240 |
| FORBES KENDALL | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Sep 24, 2026 | 1,651,060 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 6.51% | 3,241,612 | 136.36M | Jun 29, 2026 |
| Wellington Management Group, LLP | 3.47% | 1,729,032 | 72.73M | Jun 29, 2026 |
| Blackrock Inc. | 3.16% | 1,575,989 | 66.29M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 2.77% | 1,379,750 | 58.04M | Jun 29, 2026 |
| Woodline Partners LP | 2.62% | 1,306,340 | 54.95M | Jun 29, 2026 |
| Valiant Capital Management, L.P. | 2.38% | 1,186,658 | 49.92M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.06% | 1,028,313 | 43.26M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.65% | 820,410 | 34.51M | Sep 29, 2026 |
| Fidelity Capital Trust-Fidelity Stock Selector Small Cap Fund | 1.15% | 570,825 | 24.01M | Aug 30, 2026 |
| Putnam Funds Trust-PUTNAM CORE EQUITY FUND | 1.02% | 508,135 | 21.37M | Jul 30, 2026 |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 0.96% | 476,800 | 20.06M | Jul 30, 2026 |
| LOOMIS SAYLES FUNDS II-Loomis Sayles Small Cap Growth Fund | 0.95% | 470,706 | 19.80M | Jun 29, 2026 |